Martha Morrell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Martha morrell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Martha Morrell Today - Breaking & Trending Today

NeuroPace, Inc. (NASDAQ:NPCE) Receives $15.67 Consensus Target Price from Analysts

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target […] ....

United States , Martha Morrell , Leerink Partnrs , Geode Capital Management , Neuropace Company Profile , Securities Exchange Commission , Wells Fargo Company , Citigroup Inc , Barclays Plc , Orbimed Advisors Llc , Renaissance Technologies , Susquehanna International Group , Neuropace Inc , Cantor Fitzgerald , Get Free Report , Street Capital , Wells Fargo , Exchange Commission , International Group , Capital Management , Get Free , Neuropace Daily ,

NeuroPace (NASDAQ:NPCE) Price Target Raised to $18.00

NeuroPace (NASDAQ:NPCE – Free Report) had its price objective hoisted by Cantor Fitzgerald from $16.00 to $18.00 in a report issued on Wednesday morning, Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the stock. A number of other analysts have also recently commented on the stock. Lake Street Capital reiterated a buy rating […] ....

United States , Martha Morrell , Leerink Partnrs , Jpmorgan Chase Co , Neuropace Company Profile , Cantor Fitzgerald , Barclays Plc , Renaissance Technologies , Neuropace Inc , Wells Fargo Company , Virtu Financial , Citigroup Inc , Susquehanna International Group , Morgan Stanley , Free Report , Street Capital , Moderate Buy , Get Free Report , Neuropace Daily ,

141,616 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Purchased by EAM Investors LLC

EAM Investors LLC purchased a new position in NeuroPace, Inc. (NASDAQ:NPCE – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 141,616 shares of the company’s stock, valued at approximately $1,378,000. EAM Investors LLC owned about 0.54% of NeuroPace […] ....

United States , Martha Morrell , Leerink Partnrs , Citigroup Inc , Exchange Commission , Neuropace Inc , Geode Capital Management , Jpmorgan Chase Co , Team Investors , Morgan Stanley , Renaissance Technologies , Securities Exchange Commission , Cantor Fitzgerald , Susquehanna International Group , Barclays Plc , Free Report , International Group , Capital Management , Street Capital , Space Stock Down , Visit Holdingschannel , Neuropace Daily , Nasdaq Npce , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

EAM Investors LLC Purchases Shares of 141,616 NeuroPace, Inc. (NASDAQ:NPCE)

EAM Investors LLC purchased a new stake in NeuroPace, Inc. (NASDAQ:NPCE – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 141,616 shares of the company’s stock, valued at approximately $1,378,000. A number of other institutional investors also recently modified […] ....

United States , Martha Morrell , Neuropace Inc , Jpmorgan Chase Co , Geode Capital Management , Blackrock Inc , Citigroup Inc , Neuropace Company Profile , Exchange Commission , Securities Exchange Commission , Cantor Fitzgerald , Morgan Stanley , Team Investors , Renaissance Technologies , Wells Fargo Company , Free Report , Street Corp , Capital Management , Visit Holdingschannel , Neuropace Daily , Nasdaq Npce , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

NeuroPace (NASDAQ:NPCE) Given New $16.00 Price Target at Wells Fargo & Company

NeuroPace (NASDAQ:NPCE – Get Free Report) had its target price hoisted by Wells Fargo & Company from $9.00 to $16.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective indicates a potential upside of 1.14% from the company’s […] ....

United States , Leerink Partnrs , Martha Morrell , Geode Capital Management , Jpmorgan Chase Co , Barclays Plc , Neuropace Inc , Wells Fargo Company , Morgan Stanley , Citigroup Inc , Cantor Fitzgerald , Susquehanna International Group , Renaissance Technologies , Get Free Report , Wells Fargo , International Group , Capital Management , Neuropace Daily , Nasdaq Npce , Boost Price Target ,